What's the role of topiramate in the management of patients with hyperkinetic movement disorders?

Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 1

Abstract

Topiramate (TPM) is an O-alkyl sulfamate derivative of the naturally occurring monosaccharide D-fructose with an epileptic activity. However, it has been suggested that, in addition to its use in epilepsy, TPM could also be used in the treatment of neurological disorders, psychiatric conditions and hyperkinetic movement disorders. The clinical applications of TPM in hyperkinetic movement disorders is consistent with the multiple pharmacodynamic mechanisms e.g., the modulation of both γ-aminobutyric acidergic or glutamatergic neurotransmission and the modulation of voltage-gated ion channels or intracellular signalling pathways. The purpose of the present review is to describe the mechanisms of action of TPM and its clinical efficacy in patients with hyperkinetic movement disorders.

Authors and Affiliations

Antonio Siniscalchi, Luca Gallelli, Chiara Giofrè, Giovambattista De Sarro

Keywords

Related Articles

Antihypertensive effects of the flavonoid quercetin.

The blood pressure lowering effect of a fruit and vegetable-rich diet is a necessary dietary lifestyle measure now included the guidelines for the management of arterial hypertension. Furthermore, flavonoids represent a...

Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro.

Long-term administration of heparin can lead to development of osteoporosis. The aim of the present study was to examine the effects of standard heparin and low-molecular-weight heparins (nadroparin, enoxaparin, parnapar...

Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.

Aspirin exerts its analgesic, antipyretic and anti-inflammatory actions by inhibiting the enzyme cyclooxygenase and thus preventing the formation and release of prostaglandins. The elucidation by John Vane of the mechani...

Cyclooxygenase inhibitors: a novel direction for Alzheimer's management.

Research in Alzheimer's disease (AD) currently includes various cellular, molecular, genetic, clinical and therapeutic approaches. The cytopathological significance of oxidative damage has been studied in neurons of AD p...

Activity of essential phospholipids (EPL) from soybean in liver diseases.

Essential phospholipids (EPL) contain a highly purified extract of polyenylphosphatidylcholine (PPC) molecules from soybean. The main active ingredient is 1,2-dilinoleoylphosphatidylcholine (DLPC), which differentiates i...

Download PDF file
  • EP ID EP130053
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

Antonio Siniscalchi, Luca Gallelli, Chiara Giofrè, Giovambattista De Sarro (2012). What's the role of topiramate in the management of patients with hyperkinetic movement disorders?. Pharmacological Reports, 64(1), 24-30. https://europub.co.uk/articles/-A-130053